Safety Profile Toxicology studies using doses far exceeding human therapeutic ranges have not identified significant adverse effects
MAOIs are deaminators of neurotransmitters, resulting in deactivation of, and affecting the number of, neurotransmitters in the synaptic cleft, thereby regulating neurotransmitter levels and brain mood function
It provides information on fructose, lactose, gluten, histamine, salicylates and sortibol in foods
preclinical literature explores model-specific outcomes
After consideration of public comments, we are finalizing the inclusion of the MIPS Q492: Risk-Standardized Acute Unplanned Cardiovascular-Related Admission Rates for Patients with Heart Failure measure in the heart failure quality measure set as proposed as 512.725(b)(1)